EGFRVIII ACTIVATES A DISTINCT PATHWAY THAN WILD-TYPE EGFR BUT THE FINAL DECISION BELONGS TO WILD-TYPE EGFR

被引：0
|
作者：
Treda, Cezary [1 ]
Stoczynska-Fidelus, Ewelina [1 ]
Piaskowski, Sylwester [1 ]
Grzela, Dawid [1 ]
Zieba, Jolanta [1 ]
Walczak, Maciej [1 ]
Banaszczyk, Mateusz [1 ]
Peciak, Joanna [1 ]
Rieske, Piotr [1 ]
机构：
[1] Celther Polska Sp Zoo, Lodz, Poland
来源：
ANTICANCER RESEARCH | 2014年 / 34卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
658
引用
收藏
页码：6216 / 6217
页数：2
相关论文
共 50 条
  • [1] DISTINCT FUNCTIONAL ROLES OF WILD-TYPE EGFR AND ITS MUTANT EGFRVIII IN GLIOBLASTOMA DEVELOPMENT
    Miletic, H.
    Rosland, G. V.
    Eskilsson, E.
    Vaelk, K.
    Keunen, O.
    Jahedi, R.
    Azuaje, F.
    Stieber, D.
    Foerster, S.
    Ritter, C.
    [J]. NEURO-ONCOLOGY, 2014, 16
  • [2] DISTINCT FUNCTIONAL ROLES OF WILD-TYPE EGFR AND ITS MUTANT EGFRvIII IN GLIOBLASTOMA DEVELOPMENT
    Rosland, Gro V.
    Talasila, Krishna M.
    Eskilsson, Eskil
    Jahedi, Roza
    Azuaje, Francisco
    Stieber, Daniel
    Foerster, Sarah
    Varughese, Jobin
    Ritter, Christoph
    Niclou, Simone P.
    Bjerkvig, Rolf
    Miletic, Hrvoje
    [J]. NEURO-ONCOLOGY, 2013, 15 : 6 - 6
  • [3] EGFR inhibitors for wild-type EGFR NSCLC: to use or not to use?
    Jassem, Jacek
    Dziadziuszko, Rafal
    [J]. LANCET ONCOLOGY, 2013, 14 (10): : 916 - 917
  • [4] Pyrene-Modified DNA Aptamers with High Affinity to Wild-Type EGFR and EGFRvIII
    Zavyalova, Elena
    Turashev, Askar
    Novoseltseva, Anastasia
    Legatova, Valeriia
    Antipova, Olga
    Savchenko, Ekaterina
    Balk, Sonja
    Golovin, Andrey
    Pavlova, Galina
    Kopylov, Alexey
    [J]. NUCLEIC ACID THERAPEUTICS, 2020, 30 (03) : 175 - 187
  • [5] Endocytosis of EGFR and resistance to gefitinib in NSCLC cells with wild-type EGFR
    Jo, Ukhyun
    Sung, Jae Sook
    Park, Kyong Hwa
    Whang, Young Mi
    Kim, Seung Tae
    Kim, Yeul Hong
    [J]. CANCER RESEARCH, 2012, 72
  • [6] EGFR endocytosis is a rational target in lung cancer with wild-type EGFR
    Jo, Ukhyun
    Park, Kyong Hwa
    Whang, Young M.
    Sung, Jae Sook
    Won, Nam Hee
    Park, Jong Kuk
    Kim, Yeul Hong
    [J]. CANCER RESEARCH, 2014, 74 (19)
  • [7] Optimisation of EGFR TKI efficiency wild-type EGFR lung cancer
    Raimbourg, Judith
    Cabart, Mathilde
    Joalland, Marie-Pierre
    Decaudin, Didier
    Deplater, Ludmilla
    Lanoe, Didier
    Douillard, Jean-Yves
    Bennouna, Jaafar
    Vallette, Francois
    Lalier, Lisenn
    [J]. CANCER RESEARCH, 2015, 75
  • [8] Significance of the estrogen signaling pathway in EGFR wild-type lung adenocarcinoma.
    Tanaka, Kazumi
    Shimizu, Kimihiro
    Nagashima, Toshiteru
    Ohtaki, Yoichi
    Kaira, Kyoichi
    Horiguchi, Jun
    Oyama, Tetsunari
    Takeyoshi, Izumi
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [9] EGFR endocytosis is a novel therapeutic target in lung cancer with wild-type EGFR
    Jo, Ukhyun
    Park, Kyong Hwa
    Whang, Young Mi
    Sung, Jae Sook
    Won, Nam Hee
    Park, Jong Kuk
    Kim, Yeul Hong
    [J]. ONCOTARGET, 2014, 5 (05) : 1265 - 1278
  • [10] Optimisation of EGFR TKI efficiency in the therapeutic scheme of EGFR wild-type lung cancer
    Cabart, Mathilde
    Raimbourg, Judith
    Lalier, Lisenn
    Bennouna, Jaafar
    Vallette, Francois
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
12345